Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company, is laying off 83 employees by June 30, marking a significant reduction in its workforce. Founded in 1717 in Osaka, Japan, Ono Pharma focuses on developing innovative medicines in various therapeutic areas including oncology, neurology, and immunology. As of 2024, it employs nearly 4,000 people globally and has been expanding its presence in the U.S. since 2020. This layoff comes amid similar announcements from other biotech firms in Massachusetts.
Ono Pharma USA is set to lay off 83 employees by June 30, reflecting a broader trend among biotech companies in the state.
Founded in 1717 and now having a significant presence in the U.S., Ono Pharma continues to develop medicines in critical fields such as oncology and neurology.
Collection
[
|
...
]